Neurotensin (NT) is a tridecapeptide distributed in the CNS, including the entorhinal cortex (EC), a structure that is crucial for learning and memory and undergoes the earliest pathological alterations in Alzheimer's disease (AD). Whereas NT has been implicated in modulating cognition, the cellular and molecular mechanisms by which NT modifies cognitive processes and the potential therapeutic roles of NT in AD have not been determined. Here we examined the effects of NT on neuronal excitability and spatial learning in the EC, which expresses high density of NT receptors. Brief application of NT induced persistent increases in action potential firing frequency, which could last for at least 1 h. NT-induced facilitation of neuronal excitability was mediated by downregulation of TREK-2 K ϩ channels and required the functions of NTS1, phospholipase C, and protein kinase C. Microinjection of NT or NTS1 agonist, PD149163, into the EC increased spatial learning as assessed by the Barnes Maze Test. Activation of NTS1 receptors also induced persistent increases in action potential firing frequency and significantly improved the memory status in APP/PS1 mice, an animal model of AD. Our study identifies a cellular substrate underlying learning and memory and suggests that NTS1 agonists may exert beneficial actions in an animal model of AD.
Introduction
Progressive deterioration of cognitive performance is a critical characteristic of Alzheimer's disease (AD), and improving cognitive function represents a major therapeutic approach for this disease. Current available therapies for AD, including the cholinesterase inhibitors (Pepeu and Giovannini, 2009 ) and the partial NMDA receptor antagonist memantine (van Marum, 2008) , provide only minimal benefit for a limited period to a subset of patients. Finding drugs that can improve memory is still a major method to relieve the symptoms of AD patients. Accumulating evidence demonstrates that neurotensin (NT), a tridecapeptide, and NT receptors are densely distributed in the entorhinal cortex (EC) (Wolf et al., 1994 (Wolf et al., , 1995 Lahti et al., 1998; Hamid et al., 2002) , a structure that is essential for learning and memory and undergoes the earliest pathological alteration in AD (Gó mez-Isla et al., 1996) . However, the physiological functions of NT in the EC, especially in learning and memory, and the therapeutic potential of NT receptor modulators for AD have not been determined.
NT-containing cell bodies and fibers have been detected in the EC and the structures that have inputs to the EC, such as olfactory tubercle, subiculum, amygdale, and claustrum (Chen et al., 1988; Atoji et al., 1995) . NT interacts with three different types of NT receptors: NTS1, NTS2, and NTS3, of which NTS1 and NTS2 are G-protein-coupled (Vincent et al., 1999) . NTS1 has higher affinity for NT and is blocked by the selective antagonist SR48692, whereas NTS2 has lower affinity for NT and is sensitive to levocabastine. NTS1 is functionally coupled to phospholipase C (PLC) pathway via Gq proteins (Hermans and Maloteaux, 1998; Vincent et al., 1999) . The pharmacological and signaling properties of NTS2 are still controversial. In particular, it is unclear whether NT acts as an agonist, inverse agonist, or antagonist for this type of receptor. The functions of NTS2 are unclear, although it may be involved in NT-induced internalization of receptorligand complexes (St-Gelais et al., 2006) . NTS3 is a single trans-membrane domain receptor and binds NT with high affinity (Vincent et al., 1999) .
The EC is closely related to consolidation and recall of memories (Dolcos et al., 2005; Steffenach et al., 2005) and AD (Hyman et al., 1984; Kotzbauer et al., 2001) . NT receptors are densely expressed in the EC, especially in the superficial layers (Wolf et al., 1994 (Wolf et al., , 1995 Lahti et al., 1998; Hamid et al., 2002) . However, the effects of NT in the EC, an indispensable structure in memory processing, and the potential uses of NT receptor modulators in AD therapy have not been determined. In the present study, we determined the roles of NT in facilitation of neuronal excitability and spatial memory and tested the effects of NT and PD149163, a small-molecule NTS1 agonist that can penetrate the blood-brain barrier, on improving spatial memory ability in an AD mouse model. Our research unraveled an unidentified cellular mechanism for memory and provides a potential approach for AD therapy.
Materials and Methods
Slice preparation. The ages of the animals used for electrophysiological recordings were postnatal 3-5 weeks for Sprague Dawley rats, individual knock-out (KO), and their corresponding wild-type (WT, C57BL/6J) mice. APP/PS1 mice (8 -10 months) were obtained from the The Jackson Laboratory: strain 005864 B6.Cg-Tg(APPswe,PSEN1dE9)85Dbo/J. Agematched C57BL/6J WT mice provided the control as described previously (Dhawan and Combs, 2012) . Horizontal brain slices (400 m) were prepared as described previously (Wang et al., 2012 (Wang et al., , 2013 Zhang et al., 2014) , except with the following modifications. After being deeply anesthetized with isoflurane, animals were decapitated and their brains were dissected out in ice-cold saline solution that contained the following (in mM): 130 N-methyl-D-glucamine (NMDG)-Cl, 24 NaHCO 3 , 3.5 KCl, 1.25 NaH 2 PO 4 , 0.5 CaCl 2 , 5.0 MgCl 2 , and 10 glucose, saturated with 95% O 2 and 5% CO 2 (pH 7.4, adjusted with HCl). Slices were then incubated in the above solution, except that NMDG-Cl was replaced with NaCl at 35°C for 1 h for recovery and then kept at room temperature (ϳ24°C) until use. We found that these procedures yielded more viable slices from old animals.
Whole-cell recordings from entorhinal neurons. Whole-cell patch-clamp recordings using 4 Multiclamp 700B amplifiers (Molecular Devices) in current-or voltage-clamp mode were made from the principal neurons in the EC visually identified with infrared video microscopy (Olympus BX51WI) and differential interference contrast optics as described previously (Deng et al., 2006 (Deng et al., , 2010 Wang et al., 2011) . Recordings were conducted at room temperature (ϳ23°C). The recording electrodes were filled with the following (in mM): 100 potassium gluconate, 0.6 EGTA, 5 MgCl 2 , 8 NaCl, 2 ATPNa 2 , 0.3 GTPNa, phosphocreatine 7, and 33 HEPES (pH 7.3 adjusted with KOH). The extracellular solution comprised the following (in mM): 130 NaCl, 24 NaHCO 3 , 3.5 KCl, 1.25 NaH 2 PO 4 , 2.5 CaCl 2 , 1.5 MgCl 2 , and 10 glucose, saturated with 95% O 2 and 5% CO 2 , pH 7.4. Data were filtered at 2 kHz, digitized at 10 kHz, acquired on-line, and analyzed off-line using pCLAMP 9 or pCLAMP10 software (Molecular Devices).
Action potential (AP) firing was induced by injecting a positive current (ϳ30 -100 pA) to bring the resting membrane potential (RMP) to ϳϪ50 mV to induce a basal AP firing frequency of 0.2-1 Hz unless stated otherwise. Drugs were applied after the AP firing had been stable for 5-10 min. Frequency of APs was calculated by Mini Analysis 6.0.1 (Synaptosoft). Holding currents (HCs) at Ϫ55 mV were recorded in the extracellular solution containing TTX (0.5 M) every 3 s and then averaged per minute. We subtracted the average of the HCs recorded for the last minute before the application of NT from those recorded at different time points to zero the basal level of HCs for better comparison unless stated otherwise. I-V curves were constructed by using a ramp protocol from Ϫ140 to 0 mV at a speed of 0.1 mV/ms in the external solution supplemented with (in M) 0.5 TTX, 100 CdCl 2 , 10 DNQX, 100 DL-APV, 10 bicuculline, and 2 CGP55845 to block synaptic transmission and other voltage-gated ion channels. We compared the I-V curves recorded before and after the application of NT for 5-10 min.
EPSPs were recorded from layer II stellate neurons by placing a stimulation electrode in layer I to stimulate glutamatergic inputs in the extracellular solution containing bicuculline (10 M) and CGP55845 (2 M) to block GABAergic transmission. To prevent the propagation of epileptic activity in the presence of GABAergic inhibitors, a cut was made along the middle line of layer III (Wang et al., 2012 (Wang et al., , 2013 . The intracellular solution was either the above K ϩ -gluconate-containing intracellular solution or the intracellular solution in which K ϩ was replaced by the same concentration of Cs ϩ . The stimulation intensity was set to the level that produced ϳ50% of the maximal EPSP amplitude. The stimulation frequency was set at 0.2 Hz. The numbers of APs were counted within 150 ms after the stimulation artifact.
Transfection and electrophysiological recordings from transfected cells. Detailed procedures for transfection of HEK293 cells and electrophysiological recordings from the transfected cells were described previously . Briefly, HEK293 cells were transfected with NTS1 alone, or together with WT TREK-2 channels or TREK-2 mutant. GFP was cotransfected for each experiment to identify the transfected cells. cDNA constructs coding for a human NT Type 1 receptor (GenBank accession number AY429106, subcloned into pCDNA3.1 vector) was obtained from the Missouri S&T cDNA Resource Center (www.cdna.org). cDNA for the mutant TREK-2 channels was kindly provided by Dr. Donghee Kim (Rosalind Franklin University of Medicine and Science, Chicago) (Kang et al., 2006) . cDNA constructs coding for TREK-2 (NM_021161, subcloned into the pCMV6-XL4 vector) were purchased from Origene. An empty pEGFP N-3 GFP fusion protein vector (GenBank accession number U57609) was purchased from Clontech. Transfected HEK293 cells were subsequently used for electrophysiological recordings 24 -48 h after transfection. HCs at Ϫ55 mV were recorded from the HEK293 cells that showed fluorescence under a fluorescence microscope (Olympus 1X70) by whole-cell recordings. The extracellular solution contained (in mM) 130 NaCl, 3 KCl, 2 MgCl 2 , 2 CaCl 2 , 1.25 NaH 2 PO 4 , 10 HEPES, and 10 glucose (pH adjusted to 7.4 using NaOH and HCl). The above K ϩ -gluconate internal solution was used for this experiment. A continuous gravity perfusion system (flow, 5-7 ml/min) was used to change solutions.
Immunocytochemistry. The methods for immunocytochemistry were described previously (Deng and Lei, 2008; Deng et al., 2009; Ramanathan et al., 2012) . Briefly, horizontal sections (20 m) from rat brain were washed in 0.1 M PBS and then treated with 0.3% hydrogen peroxide (H 2 O 2 ) for 10 min to quench endogenous peroxidase activity. After being rinsed in 0.1 M PBS containing 1% Triton X-100 and 5% normal donkey serum for 30 min, sections were incubated with the primary goat antibody to NTS1 (Santa Cruz Biotechnology, sc-7598) at a dilution of 1:200 at 4°C for 12 h. Sections were incubated at room temperature initially with biotinylated donkey anti-goat IgG (Immunocruz Staining System, Santa Cruz Biotechnology) for 1 h and then with HRPstreptavidin complex (Immunocruz Staining System) for 1 h. After each incubation, sections were washed three times for a total of 30 min. Diaminobenzidine (Immunocruz Staining System) was used for a color reaction to detect the positive signals. Finally, sections were mounted on slides, dehydrated through an alcohol range, cleared in xylene, and covered with coverslips. We stained ϳ10 nonadjacent sections for each rat, and each staining was repeated by using 3 rats. For a control, NTS1 antibody was preabsorbed with the corresponding blocking peptide (Santa Cruz Biotechnology, sc-7598P) before being applied to the sections, and the other experimental procedures were the same as described above.
Immunoprecipitation and Western blot. Brain slices containing the EC were obtained from Sprague Dawley rats, WT (C57BL/6J) and TREK-2 KO mice (n ϭ 6). For each animal, horizontal brain slices were cut initially, and the EC region was punched out from the slices under a microscope. The isolated brain region was treated with 0.25 M NT in the oxygenated extracellular solution for 5 min and then incubated in NTfree extracellular solution for varied times as described in Results. Tissue lysates from the EC were prepared as described previously ). The lysates were centrifuged at 14,000 rpm for 10 min to remove the insoluble materials, and protein concentrations in the supernatant were determined (Bradford, 1976) . Equivalent proteins were added to Eppendorf tubes, and TREK-2 protein from these lysates was immunoprecipitated using goat TREK-2 antibody (1 g antibody/mg protein; sc-11560, Santa Cruz Biotechnology) by overnight rocking at 4°C. Protein was then added to the agarose beads (40 l beads/IP, Protein A/G PLUS, Agarose, Santa Cruz Biotechnology) and rocked at room temperature for 2 h. Beads were spun down and buffer was aspirated. Beads were then rinsed with cold RIPA buffer for ϳ3-5 times. Equal amount of sample buffer was added to the beads and then boiled for 5 min at 95°C. The immunoprecipitates were resolved by SDS-PAGE and Western blotted with anti-phosphoserine antibody (Zymed Laboratories) (Glogauer et al., 1998; Nishimura et al., 1998; Yagi et al., 1999) . Detailed methods for Western blot were described previously Ramanathan et al., 2012) .
Barnes Maze Test. Detailed procedures for cannulation and microinjection to the EC were described previously . For the experiments with Sprague Dawley rats (male, 150 -200 g), the Barnes Maze Test consists of a rotatable circular platform (1.22 m in diameter and 1 m from the floor) with 18 holes (9.5 cm in diameter) evenly spaced around the periphery. A removable box was placed underneath one of the holes for escape. The escape hole remained fixed in one location for each animal for all the trials. Visual cues were placed on the walls of the room and on two stands located 50 cm from the platform for spatial references. An auditory buzzer producing 80 -100 dB was used as an aversive stimulus. On the first day of trials, each animal was placed on the platform without the escape box for 5 min allowing the animal to familiarize with the maze. The escape box was then placed, and the animal was placed into the escape box for 2 min. At the beginning of each trial, a closed starting chamber was used to place the animal in the center of the platform. The auditory buzzer was then switched on. After ϳ15 s, the starting chamber was removed and the animal was allowed to explore the maze for 3 min. Once the animal entered the escape box, the auditory aversive stimulus was stopped. If the animal failed to enter the escape box in 3 min, it was guided to the escape box by the experimenter and the latency was counted as 180 s. The animal was allowed to remain in the box for 1 min before the next trial. The platform and the escape box were wiped with 70% ethanol after each trial to eliminate the use of olfactory cues to locate the target hole. Each animal was subject to a session of 3 trials per day. The performance of the animal was recorded by Videomex-One monitor system (Columbus Instruments). For the experiments with mice, the experimental methods were generally the same as described above, except for the following differences. First, the Barnes Maze Test for mice consists of 40 holes. Second, the age of the mice was ϳ2 months (30 -35 g) or 8 -10 months for the APP/PS1 mice or age-matched control WT (C57BL/6J) mice, and the coordinates for the guide cannulae were anteroposterior (Ϫ4 mm), mediolateral (Ϯ3.4 mm), and dorsoventral (Ϫ4.8 mm). Third, the training protocol was the same as that used for rats, except that we added another trial each day because our preliminary data suggested that more trials are required for the training of mice.
Data analysis. Data are presented as the mean Ϯ SEM. NT concentration-response curve was fit by the Hill equation as follows: I ϭ I max ϫ ͕1/͓1 ϩ ͑EC 50 /[ligand͔͒ n ͔}, where I max is the maximum response, EC 50 is the concentration of ligand producing a half-maximal response, and n is the Hill coefficient. To differentiate the involvement of TASK-1 channels, we fit the net I-V curve induced by NT with the GoldmanHodgkin-Katz (GHK) current equation: 
Results
NT induces persistent enhancement of neuronal excitability in the superficial layers of the EC via activation of NTS1 Autoradiographic studies have shown that NT-binding sites are detected in the EC, especially in layer II of the EC (Wolf et al., 1994 (Wolf et al., , 1995 Lahti et al., 1998; Hamid et al., 2002) . Accordingly, we examined the effects of NT on neuronal excitability by recording AP firing from the principal neurons in the medial EC of rats using whole-cell current-clamp configuration. The intracellular solution contained K ϩ -gluconate, and the extracellular solution was supplemented with 10 M DNQX, 50 M DL-APV to block glutamatergic, and 10 M bicuculline and 2 M CGP55845 to block GABAergic transmission. In the superficial layers (layer II/III), stellate and pyramidal neurons are the two major neuronal types in layer II (Alonso and Klink, 1993; Canto et al., 2008) , whereas pyramidal neurons are the principal neuronal type in layer III (Dickson et al., 1997) . Application of NT (0.25 M) for 5 min increased the AP firing frequency by 8.93 Ϯ 1.94-fold in stellate (n ϭ 7, p ϭ 0.004; Fig. 1A 1 ,A 2 ) and 7.58 Ϯ 1.71-fold in pyramidal (n ϭ 8, p ϭ 0.003; Fig. 1B 1 ,B 2 ) neurons of layer II. The effect of NT lasted for at least 60 min after wash in NT-free extracellular solution in our whole-cell recording configuration. We also examined the effects of NT on AP firing frequency in the pyramidal neurons of layer III and layer V. Application of NT (0.25 M) induced a much smaller increase in AP firing frequency in the pyramidal neurons of layer III (0.66 Ϯ 0.26-fold increase, n ϭ 8, p ϭ 0.04; Fig. 1C 1 ,C 2 ) but failed to significantly enhance the AP firing frequency in layer V pyramidal neurons (0.25 Ϯ 0.13-fold increase, n ϭ 9, p ϭ 0.09; Fig. 1D 1 ,D 2 ). These results demonstrate that NT selectively facilitates neuronal excitability in the superficial layers (especially layer II) of the EC, consistent with previous and our immunohistological results (see below) showing that a high density of NT receptors exists in layer II of the EC (Wolf et al., 1994; Lahti et al., 1998; Hamid et al., 2002) . Because stellate neurons are the principal neuronal type (ϳ69%) in layer II (Alonso and Klink, 1993) , we recorded from the stellate neurons to further determine the underlying ionic and signaling mechanisms for the rest of the experiments. The EC 50 of NT was measured to be 41 nM (effective concentration: 0.01-1 M; Fig.  1E ). Because the maximal effect of NT was observed at 0.25 M, we used NT at this concentration for the rest of the experiments unless stated otherwise.
Whereas NT has been reported to modulate the release of glutamate (Yin et al., 2008; Kadiri et al., 2011) and GABA (O'Connor et al., 1992; Rakovska et al., 1998; Petkova-Kirova et al., 2008) in some brain regions, NT-induced persistent increase in AP firing frequency is unlikely to be mediated by glutamate or GABA because the extracellular solution contained blockers for glutamatergic and GABAergic receptors. Inclusion of MCPG (1 mM), a broad-spectrum metabotropic glutamate receptor (mGluR) blocker, in the extracellular solution failed to alter NTinduced facilitation of AP firing (n ϭ 6, p ϭ 0.48 vs NT alone; Fig.  1F ), excluding the involvement of mGluRs. NT has also been reported to modulate the releases of acetylcholine (Ach) (Lapchak et al., 1990 (Lapchak et al., , 1991 Rakovska et al., 1998; Petkova-Kirova et al., 2008) and dopamine (DA) (Faggin et al., 1990; Reyneke et al., 1992) . Pretreatment of slices with and continuous bath application of atropine (10 M, muscarinic receptor blocker) and mecamylamine (100 M, nicotinic receptor blocker) failed to change NT-induced facilitation of AP firing frequency (n ϭ 6, p ϭ 0.44 vs NT alone; Fig. 1F ), suggesting that it is unlikely that NT facilitates neuronal excitability via releasing Ach. Furthermore, application of SCH23390 (10 M, D 1 -like receptor antagonist) and sulpiride (100 M, D 2 -like receptor antagonist) in the same fashion did not alter NT-induced enhancement of AP firing frequency (n ϭ 5, p ϭ 0.99 vs NT alone; Fig. 1F ). These results together indicate that it is unlikely that NT-induced facilitation of AP firing is mediated indirectly by modulating the release of Ach and DA. Finally, application of NT in the pure extracellular solution without any blockers for any receptors still enhanced the AP firing frequency to the same level (8.4 Ϯ 3.1-fold increase, n ϭ 6, p ϭ 0.04; data not shown) supporting a physiological role for NT-induced facilitation of neuronal excitability in the EC. Bath application of the active NT fragment (NT8 -13, 0.25 M) increased the AP firing frequency to the same level as NT (n ϭ 6, p ϭ 0.35 vs NT alone; Fig. 1F ), whereas application of the inactive fragment (NT1-8, 0.25 M) failed to increase AP firing frequency (n ϭ 7, p ϭ 0.093 vs baseline; p Ͻ 0.0007 vs NT alone; Fig. 1F ), suggesting that NT acts via activation of NT receptors.
We then tested the roles of NT receptors (NTS1 and NTS2) in NT-induced enhancement of neuronal excitability. Bath application of the selective NTS1 blocker, SR48693 (1 M, for 10 min), did not significantly alter AP firing frequency (98 Ϯ 6% of control, n ϭ 6, p ϭ 0.68; data not shown), suggesting that this compound by itself does not modulate AP firing. We then pretreated the slices with SR48692 (1 M) for ϳ20 min, and the same concentration of SR48692 was continuously bath-applied. In the presence of SR48692, application of NT increased AP firing frequency to a significantly smaller level (n ϭ 6, p ϭ 0.001 vs NT alone, two-way ANOVA; Fig. 2A ), suggesting the requirement of NTS1 receptors. Because PD149163 is a small-molecule NTS1 agonist that crosses the blood-brain barrier (Feifel et al., 2004 (Feifel et al., , 2010 Azmi et al., 2006) , we tested the effects of PD149163 on neuronal excitability recorded from stellate neurons in the EC. Bath application of PD149163 (0.25 M) robustly increased the AP firing frequency (n ϭ 10, p ϭ 0.002; Fig. 2A ), further supporting the requirement of NTS1 receptors. However, pretreatment of slices with and continuous bath application of NTS2 receptor antagonist levocabastine (30 M) was without effect on NTinduced facilitation of AP firing frequency (n ϭ 10, p ϭ 0.35 vs NT alone; Fig. 2A ), suggesting that NTS2 is not necessary for NT-induced facilitation of neuronal excitability. We further tested the roles of NT receptors in NT-induced facilitation of neuronal excitability by using NT receptor KO mice as previously (Maeno et al., 2004) . Application of NT did not significantly increase the AP firing frequency in NTS1 KO mice (n ϭ 12 cells from 4 mice, p ϭ 0.98; Fig. 2B ), whereas application of NT still robustly increased the AP firing frequency in NTS2 KO (n ϭ 12 cells from 4 mice, p Ͻ 0.0001; Fig. 2B ) and WT (n ϭ 10 cells from 3 mice, p Ͻ 0.0001; Fig. 2B ) mice, further confirming the involvement of NTS1. Consistent with our electrophysiological data, immunoreactivity for NTS1 was mainly detected in the superficial layers (especially layer II) of the EC (Fig. 2C) . Western blot showed a single protein band of ϳ60 kDa in the lysates of the EC prepared from rats and WT mice, corresponding to the molecular mass of NTS1 receptors (Martorana et al., 2006) , whereas no band was detected in this range of molecular mass for the lysates of the EC from NTS1 KO mice (Fig. 2D ).
NTS1 receptors are coupled to G-proteins. We next tested the roles of G-proteins in NT-induced facilitation of neuronal excitability. Intracellular dialysis of G-protein inhibitor GDP-␤-S (2 mM) blocked NT-induced enhancement of AP firing frequency (n ϭ 7, p ϭ 0.79; Fig. 2E ). The major intracellular signal activated by NTS1 is PLC␤, which hydrolyzes PIP 2 to produce IP 3 to facilitate intracellular Ca 2ϩ release and diacylglycerol to activate PKC. We accordingly examined the roles of this pathway. Slices were pretreated with U73122 (10 M), a PLC inhibitor, and the same concentration of U73122 was continuously bath-applied. Under these conditions, application of NT failed to change the AP firing frequency significantly (n ϭ 6, p ϭ 0.12; Fig. 2E ), whereas application of U73343 (10 M), the inactive analog, in the same fashion did not significantly alter NT-induced enhancement of AP firing frequency (n ϭ 6, p Ͻ 0.0001 vs baseline; Fig.  2E ). Similarly, application of edelfosine (10 M), another PLC inhibitor, blocked NT-induced facilitation of AP firing frequency (n ϭ 9, p ϭ 0.09; Fig. 2E ). We then used PLC␤ KO mice to further confirm our results. Among the 4 isoforms of PLC␤ (PLC␤1-4), PLC␤1 is expressed in the hippocampal formation (Watanabe et al., 1998) . We therefore used PLC␤1 KO mice as previously described (Deng et al., 2006; to examine the roles of PLC in NT-induced facilitation of AP firing. Application of NT robustly enhanced the AP firing frequency (n ϭ 10 cells, p Ͻ 0.0001) in slices cut from 3 WT mice, whereas it increased the AP firing frequency to a significantly smaller level (n ϭ 13 cells) in slices cut from 4 PLC␤1 KO mice ( p Ͻ 0.0001 vs WT mice; Fig.  2E ). Together, these results demonstrate that NT-mediated enhancement of neuronal excitability requires the function of PLC␤1. We then tested the roles of PKC and intracellular Ca 2ϩ release in NT-induced facilitation of neuronal excitability. Slices were pretreated with GF109203X (1 M) and Ro318220 (1 M) separately, and the same concentrations of the PKC inhibitors were continuously bath-applied. Under these circumstances, application of NT failed to increase AP firing frequency significantly in the presence of GF109203X (n ϭ 6, p ϭ 0.2; Fig. 2F ) or Ro318220 (n ϭ 6, p ϭ 0.83; Fig. 2F ), demonstrating the involvement of PKC. Because PKC is an upstream activator of MEK/ERK in some cell types (Hu and Gereau, 2003) , we also tested whether MEK/ERK is required for NT-induced increase in AP firing frequency. Slices were pretreated with the selective MEK/ERK inhibitor PD98059 (50 M) for Ͼ2 h and the extracellular solution continued to contain the same concentration of PD98059. Under these circumstances, bath application of NT still enhanced the AP firing frequency to a comparable level (n ϭ 5, p ϭ 0.02; Fig. 2F ), suggesting that MEK/ERK activity is not required for NTinduced facilitation of neuronal excitability. To test the involvement of IP 3 receptors, we included xestospongin C (5 M, IP 3 receptor inhibitor) in the recording pipettes and waited for ϳ20 min after the formation of whole-cell configuration. In this condition, application of NT still increased the AP firing frequency to a comparable level (n ϭ 6, p ϭ 0.83 vs NT alone; Fig. 2F ). Similarly, depletion of intracellular Ca 2ϩ stores by including thapsigargin (10 M) in the pipettes for 20 min did not significantly alter NT-induced facilitation of AP firing frequency (n ϭ 6, p ϭ 0.41 vs NT alone; Fig. 2F ). These results suggest that intracellular Ca 2ϩ release is not required for NT-induced increases in AP firing. We then included BAPTA (10 mM) in the recording pipettes to chelate intracellular Ca 2ϩ . In the presence of BAPTA, bath application of NT increased the AP firing frequency to a significantly smaller level (n ϭ 7, p ϭ 0.007 vs NT alone; Fig. 2F ). Because NT still significantly increased the AP firing frequency in the extracellular solution without Ca 2ϩ (prepared by replacing extracellular Ca 2ϩ with the same con- centration of Mg 2ϩ and adding 1 mM EGTA, n ϭ 9, p ϭ 0.013; Fig. 2F ), one explanation for the effect of BAPTA is that a certain basal level of intracellular Ca 2ϩ is required for the activation of signaling molecules, such as PLC␤ and PKC.
NT-induced facilitation of AP firing is generated by membrane depolarization We recorded RMPs in the presence of TTX (0.5 M) to block AP firing. Application of NT generated membrane depolarization (control: Ϫ57.7 Ϯ 1.2 mV, NT: Ϫ53.2 Ϯ 2.0 mV, n ϭ 6, p ϭ 0.006; Fig.  3A ) and significantly increased the input resistance assessed by injection of a negative current (Ϫ50 pA for 500 ms) before (115 Ϯ 6 M⍀) and after (133 Ϯ 6 M⍀) NT application (n ϭ 6, p ϭ 0.002; Fig. 3A , inset). We then recorded the HCs at Ϫ55 mV, a potential close to the RMPs of these neurons. Application of NT generated a net inward HC (Ϫ44.5 Ϯ 5.4 pA, n ϭ 16, p Ͻ 0.001; Fig. 3B ), indicating that NT increases neuronal excitability by generating membrane depolarization.
Cationic channels are not involved in NT-induced membrane depolarization
We probed the ionic mechanisms whereby NT generates membrane depolarization. NT could cause depolarization by opening a cationic conductance and/or by inhibiting a background K ϩ conductance. We accordingly tested these possibilities by replacing the intracellular K ϩ with Cs ϩ . Application of NT failed to induce an increase in inward HCs when intracellular K ϩ was replaced with Cs ϩ (4.6 Ϯ 1.9 pA, n ϭ 7, p ϭ 0.06; Fig. 3B ), suggesting the involvement of K ϩ channels. We further examined whether there is a role for cationic channels by performing the following experiments. First, we replaced extracellular NaCl with NMDG-Cl and Ca 2ϩ with Mg 2ϩ because, if cationic channels are involved, influx of extracellular Na ϩ and Ca 2ϩ would be the ions to mediate the inward currents. However, in this condition, application of NT still induced a comparable inward HC (n ϭ 8, p ϭ 0.45 vs the inward HCs in control condition; Fig. 3B ). Second, we examined the effects of other cationic channel blockers. Pretreatment of slices with and continuous bath application of SKF96365 (50 M, an inhibitor of receptor-operated cationic channels, n ϭ 6, p ϭ 0.85), Gd 3ϩ (10 M, n ϭ 7, p ϭ 0.37), La 3ϩ (10 M, n ϭ 7, p ϭ 0.65), or ZD7288 (20 M, an inhibitor of Ih channels, n ϭ 6, p ϭ 0.57), failed to exert significant effects on NT-induced increases in inward HCs, demonstrating that NT-induced depolarization is not mediated by activation of a cationic conductance (Fig. 3C) .
NT has been reported to inhibit Na ϩ /K ϩ pump (Ló pez Ordieres and Rodríguez de Lores Arnaiz, 2000), and this pump ,butdepletionofextracellularK ϩ significantlyenhancedNT-induced HCs. *p Ͻ 0.05 versus NT alone. D, Voltage-current relationship induced by a ramp protocol from Ϫ140 to 0 mV at a speed of 0.1 mV/ms before and during the application of NT. Subtraction of the current before the application of NT generated a net current. The traces were averagesfrom5cells.ThereversalpotentialwasϳϪ87mV,closetothecalculatedK ϩ reversalpotential(Ϫ85.4mV).Inset,NT-induced net current could not be fit by GHK equation, suggesting that the channels inhibited by NT were not TASK channels.E, Inclusion of Ba 2ϩ in the extracellular solution induced an inward HC but significantly reduced NT-induced increases in inward HCs. F, Bath application of NT failed to increaseAPfiringfrequencyinslicescutfromTREK-2KOmicebutstillrobustlyenhancedAPfiringfrequencyinslicecutfromWTmice.
normally creates a concentration gradient by moving 3 Na ϩ out of the cell and 2 K ϩ into the cells. NT-mediated inhibition of this pump should create a net accumulation of Na ϩ inside the cells resulting in depolarization. Because extracellular K ϩ is necessary for the function of the Na ϩ /K ϩ pump, we replaced the extracellular K ϩ (3.5 mM) with the same concentration of Na ϩ . Instead of reducing the inward HCs, removal of extracellular K ϩ resulted in a significant increase in HCs (Ϫ83.5 Ϯ 18.8 pA, n ϭ 6, p ϭ 0.012 vs NT alone, Fig. 3C ), suggesting that NT-induced depolarization is unlikely the result of the inhibition of Na ϩ /K ϩ pump but may be relevant to K ϩ movement across the membrane (see below).
NT generates membrane depolarization by inhibiting TREK-2 channels
We further probed the involvement of K ϩ conductance. We used a ramp protocol (from Ϫ140 to 0 mV) to construct the voltagecurrent relationship before and just after the application of NT. The intracellular solution contained K ϩ -gluconate, and the extracellular K ϩ concentration was 3.5 mM. Under these circumstances, application of NT induced a current with a reversal potential of Ϫ86.7 Ϯ 1.5 mV (n ϭ 5; Fig. 3D ). The measured reversal potential was close to the calculated K ϩ reversal potential (Ϫ85.4 mV) in our recording condition further confirming that NT increases neuronal excitability by inhibiting a background K ϩ conductance. We next characterized the properties of the involved K ϩ channels. NT-induced increases in inward HCs were not significantly changed by including tetraethylammonium (TEA, 10 mM, n ϭ 9, p ϭ 0.66), Cs ϩ (3 mM, n ϭ 6, p ϭ 0.51), or 4-aminopyridine (4-AP, 2 mM, n ϭ 6, p ϭ 0.78) in the extracellular solution (Fig. 3C) . Application of the selective inward rectifier K ϩ channel inhibitor tertiapin-Q (100 nM) did not significantly alter NT-induced changes in HCs (n ϭ 7, p ϭ 0.97; Fig. 3C ). Furthermore, NT-induced increases in inward HCs were not sensitive to extracellular application of Zn 2ϩ (100 M, n ϭ 8, p ϭ 0.63; Fig. 3C ).
The above results prompted us to test the role of the two-pore domain K ϩ (K 2P ) channels because K 2P channels are involved in controlling RMPs and usually insensitive to the classic K ϩ channel blockers (Lesage and Lazdunski, 2000; Bayliss et al., 2003; Lesage, 2003) . Because some K 2P channels are sensitive to Ba 2ϩ , we tested the roles of Ba 2ϩ in NT-induced increases in inward HCs. Application of Ba 2ϩ (3 mM) alone generated an inward HC (Ϫ78.1 Ϯ 18.2 pA, n ϭ 9, p ϭ 0.003; Fig. 3E ), and it also significantly inhibited NT-induced inward HCs (Ϫ20.1 Ϯ 2.1 pA, n ϭ 9, p ϭ 0.001 vs NT alone; Fig. 3E ), suggesting the involvement of Ba 2ϩ -sensitive K 2P channels. Among the K 2P channels, TASK-1 , TASK-3 (Kim et al., 2000; Han et al., 2002) , TREK-1 ), TREK-2 (Bang et al., 2000 Han et al., 2002) , and TWIK-1 and TRESK (Sano et al., 2003; Kang et al., 2004 ) are sensitive to Ba 2ϩ . TRESK channels are unlikely to be involved because they are expressed in the spinal cord and other organs but not in the brain (Sano et al., 2003; Kang et al., 2004) . Among the remaining 5 K 2P channels, the EC expresses higher densities of TASK-1 and TREK-2 ). Because TASK channel currents show GHK-type rectification (Lesage and Lazdunski, 2000; Bayliss et al., 2003) and fitting of the NT-induced net I-V curve by GHK equation demonstrated remarkable deviation (Fig. 3D, inset) , suggesting that TASK-1 channels are unlikely to be the target for NT, we focused on TREK-2 channels by using TREK-2 KO mice as described previously (Guyon et al., 2009 ). Application of NT induced an inward HC (Ϫ38.8 Ϯ 6.1 pA, n ϭ 9 cells; data not shown) and robustly increased the firing frequency of APs (n ϭ 9 cells, p Ͻ 0.001; Fig.  3F ) in slices cut from 3 WT mice, whereas it failed to induce an inward HC (Ϫ3.7 Ϯ 2.5 pA, n ϭ 9 cells, p ϭ 0.19; data not shown) and did not increase AP firing frequency (n ϭ 9 cells, p ϭ 0.32; Fig. 3F ) in slices cut from 3 TREK-2 KO mice. However, the RMPs of stellate neurons in TREK-2 KO mice (Ϫ59.7 Ϯ 1.1 mV, n ϭ 9 cells from 3 mice) were not significantly different ( p ϭ 0.25) from those of WT mice (Ϫ61.4 Ϯ 0.9 mV, n ϭ 9 cells from 3 mice; data not shown). Together, these data indicate that NT facilitates neuronal excitability by inhibiting TREK-2 channels.
Activation of NTS1 inhibits TREK-2 currents via PLC/PKC pathway in HEK293 cells cotransfected with NTS1 and TREK-2 channels
We further probed the involvement of TREK-2 channels by using whole-cell recordings from the HEK293 cells expressing NTS1 and TREK-2 channels ). Bath application of NT (0.25 M) induced an inward HC recorded at Ϫ55 mV in HEK293 cells cotransfected with NTS1 and TREK-2 channels (n ϭ 8, p ϭ 0.002; Fig. 4 A, B) . However, bath application of NT (0.25 M) did not change the HCs recorded at Ϫ55 mV in HEK293 cells transfected with TREK-2 channels alone (n ϭ 5, p ϭ 0.82; Fig. 4B ) or NTS1 alone (n ϭ 6, p ϭ 0.86; Fig. 4B ). We further determined the roles of PLC, PKC, and intracellular Ca 2ϩ release in NT-mediated depression of TREK-2 channels in HEK293 cells cotransfected with NTS1 and TREK-2 channels. NT-induced inward HCs were significantly reduced in the presence of PLC inhibitor (U73122, 10 M, n ϭ 8, p Ͻ 0.0001) compared with those in the presence of the inactive analog (U73343, 10 M, n ϭ 7; Fig. 4C ). Similarly, treatment of the cells with another PLC inhibitor (edelfosine, 10 M, n ϭ 8, p ϭ 0.001) significantly reduced NT-induced inward HCs compared with control (Fig. 4C) . Furthermore, NT-induced inward HCs were significantly reduced by pretreatment of transfected cells with the selective PKC inhibitor (GF109203X, 1 M, n ϭ 5, p ϭ 0.007) but were unaffected by intracellular application of xestospongin C (1 M, IP 3 receptor inhibitor, n ϭ 8, p ϭ 0.08; Fig. 4C ) or thapsigargin (10 M, n ϭ 5, p ϭ 0.051; Fig. 4C ). However, intracellular application of BAPTA (10 mM) significantly reduced NTinduced inward HCs (n ϭ 6, p ϭ 0.008; Fig. 4C ). These results demonstrate that NT-induced depolarization requires the functions of PLC and PKC. One explanation for the effect of BAPTA is that intracellular Ca 2ϩ may be required for the functions of the signaling molecules, such as PLC and PKC.
Application of NT to entorhinal slices increases serine phosphorylation of TREK-2 channels
The above experiments suggest that activation of NTS1 inhibits TREK-2 channels via PKC-dependent phosphorylation of TREK-2 channels. In accordance with our results, TREK-2 channels are phosphorylated and inhibited by PKC on serine 326 (S326) and serine 359 (S359) (Gu et al., 2002; Kang et al., 2006; Kréneisz et al., 2009) . We next tested the roles of PKC-dependent phosphorylation of these two sites in NT-mediated depression of TREK-2 channels. Because mutation of S326 and S359 to alanine Fig.  4 D, E ). These data demonstrate that NT-induced depression of TREK-2 channels is mediated by PKC-dependent phosphorylation of TREK-2 channels on S326 and S359.
We further corroborated NT-induced phosphorylation of TREK-2 channels in the EC. We treated entorhinal slices for 5 min with or without NT in the absence or presence of the PKC inhibitor (GF109203X). Slices were then lysed, and the lysates were immunoprecipitated with TREK-2 antibody. The immunoprecipitates were resolved by SDS-PAGE and Western blotted with anti-phosphoserine antibody. As shown in Figure 4F , treatment of slices with NT for 5 min induced persistent increases in the phosphorylation of TREK-2 channels when the slices were kept in NT-free solution for ϳ1 h (n ϭ 3 experiments, p Ͻ 0.01 for each). Pretreatment of slices with GF109203X blocked NTinduced increases in the phosphorylation of TREK-2 channels (n ϭ 3 experiments, p ϭ 0.8). As a control, treatment of slices cut from WT mice with NT for 5 min induced phosphorylation of TREK-2 channels, whereas no band was detected in the samples prepared from the TREK-2 KO mice with the same experimental procedures (Fig. 4F ). These results demonstrate that NTinduced depression of TREK-2 channels is mediated by PKCdependent phosphorylation of TREK-2 channels.
NT enhances EPSP-AP coupling in layer II stellate neurons
All the above experiments regarding the effects of NT on AP firing were performed by injection of small positive current to elevate the RMP to just above threshold to induce AP firing. We next tested whether NT by itself could elevate the RMPs of stellate neurons to above the threshold to induce AP firing. In 10 stellate neurons, there was no spontaneous AP firing at rest. Application of NT induced AP firing in 6 of the 10 stellate neurons. The AP firing frequency reached maximal in ϳ5 min after the beginning of NT application (141 Ϯ 26 APs/min, n ϭ 6, p ϭ 0.003; Fig.  5 A, B) . Whereas the AP firing frequency was declined after wash in NT-free extracellular solution, there was still AP firing after wash for 1 h (34 Ϯ 7 APs/min, n ϭ 6, p ϭ 0.004; Fig. 5 A, B) . Application of NT to the remaining 4 stellate neurons failed to induce AP firing but significantly elevated the RMPs (control: Ϫ58.7 Ϯ 1.3 mV, NT: Ϫ55.2 Ϯ 1.6 mV, n ϭ 4, p ϭ 0.012; data not shown). We then tested the effects of NT on EPSP-AP coupling in layer II stellate neurons by placing a stimulation electrode in layer I to stimulate the glutamatergic inputs. Application of NT induced the depolarization of the baseline of the EPSPs (control: Ϫ59.5 Ϯ 1.3 mV, NT: Ϫ54.9 Ϯ 1.6 mV, n ϭ 5, p ϭ 0.0009; Fig.  5C ,D) and facilitated EPSP-AP coupling (n ϭ 5, p ϭ 0.0003; Fig.  5C,D) . To differentiate the presynaptic and postsynaptic effects of NT, we replicated the experiment by using Cs ϩ -gluconatecontaining intracellular solution to block the depolarizing effect of NT on stellate neurons. Under these circumstances, NT failed to altered the slope (101 Ϯ 2% of control, n ϭ 9, p ϭ 0.55; Fig.  5 E, F ) of the EPSPs, suggesting that NT-mediated facilitation of EPSP-AP coupling was not mediated by modulating presynaptic glutamate release, but because of its depolarizing effect on postsynaptic stellate neurons. # p Ͻ 0.05. D, I-V curves in a HEK293 cell cotransfected with NTS1 and TREK-2 mutant before (red) and during (green) the application of NT. E, Pooled time course of the HCs recorded from HEK293 cells cotransfected with NTS1 and TREK-2 mutant in response to NT. NT did not significantly alter the HCs. F, Persistent phosphorylation of TREK-2 channels on serine was detected in the lysate of the rat EC immunoprecipitated with antibody to TREK-2 channels. As a control, application of the same experimental procedures induced phosphorylation of TREK-2 channels in the samples prepared from WT mice but not in those prepared from TREK-2 KO mice. The molecular mass of TREK-2 channels was ϳ59 kDa.
NT facilitates spatial learning and memory in Barnes Maze Test
We next probed the roles of NT in the modulation of spatial learning and memory because layer II of the medial EC is predominated by "grid" cells (Sargolini et al., 2006; Hafting et al., 2008; Brandon et al., 2011; Burgalossi et al., 2011) , which are essential for spatial navigation, and NT-induced excitation of these neurons likely plays an important role in spatial learning and memory. We examined the roles of NT in spatial learning and memory using the Barnes Maze Test. Although we previously used Morris Water Maze and measured the spatial learning and memory of animals , the advantage of Barnes Maze Test is that it is less physically taxing and less stressful to animals. After ϳ15 min after microinjection each day, rats were trained for 5 consecutive days (3 trials per day). On day 12, a probe trial was conducted without the escape box to measure the memory retention ability of the rats (Fig. 6 A, B) . Both the escape latency (F (4,36) ϭ 10.29, p Ͻ 0.001; Fig.  6C ) and travel distance (F (4,36) ϭ 9.76, p Ͻ 0.001; Fig. 6D ) of rats to locate the escape box were progressively reduced during the training sessions in control rats microinjected bilaterally with saline (0.9% NaCl, 1 l/side) into the EC. Bilateral microinjection of NT at the dose of 0.01 nmol (1 l/side) into the EC failed to significantly change the spatial learning and memory of the rats compared with that of the rats injected with saline (latency: F (1,16) ϭ 1.55, p ϭ 0.23; Fig. 6C ; distance: F (1,16) ϭ 1.21, p ϭ 0.29; Figure 6D ). However, bilateral microinjection of NT at doses of 0.1 nmol (1 l/side) and 0.3 nmol (1 l/side) into the EC significantly decreased the escape latency (0.1 nmol: F (1,16) ϭ 5.46, p ϭ 0.03; 0.3 nmol: F (1,18) ϭ 26.06, p Ͻ 0.001; Figure 6C ) and the distance traveled (0.1 nmol: F (1,16) ϭ 13.89, p ϭ 0.002; 0.3 nmol: F (1,18) ϭ 37.16, p Ͻ 0.0001; Figure 6D ) compared with those of the rats injected with saline demonstrating that NT enhances spatial learning and memory. Figure 6B displays the typical traces of rats injected with saline (upper) and NT (lower) on day 1 (left) and day 5 (middle) and day 12 (probe trial, right). Furthermore, NT significantly increased the percentage of time spent in the target quadrant in the probe trial measured on day 12 (Fig. 6E) . Together, these data indicate that NT facilitates spatial learning and memory of rats.
We then tested the involvement of NT receptors in NT-induced enhancement of spatial learning and memory by using the NT receptor KO mice. We initially tested the effects of NT on facilitation of spatial learning and memory in WT mice. Bilateral microinjection of NT (0.3 nmol) into the EC of WT mice significantly reduced the escape latency (F (1,17) ϭ 17.17, p Ͻ 0.001; Fig. 7 A, B 1 ) and the distance traveled (F (1,17) ϭ 14.88, p ϭ 0.001; Fig. 7B 2 ) compared with those of the WT mice injected with saline. Moreover, NT also significantly increased the percentage of time spent in the target quadrant in the probe trial measured on day 12 (Fig.  7A-B 3 ), indicating that NT facilitates spatial learning and memory of mice as well. We also tested the roles of PD149163, the small-molecule NTS1 agonist that can cross the blood-brain barrier, in spatial learning and memory in WT mice. Bilateral microinjection of PD149163 (0.3 nmol) into the EC of WT mice significantly reduced the escape latency (F (1,17) ϭ 12.35, p ϭ 0.003; Fig. 7B 1 ) and the distance traveled (F (1,17) ϭ 11.67, p ϭ 0.003; Fig. 7B 2 ) but significantly increased the percentage of time spent in the target quadrant in the probe trial (Fig. 7B 3 ) compared with those of the WT mice injected with saline suggesting that activation of NTS1 facilitates spatial learning and memory. Likewise, microinjection of NT (0.3 nmol) into the EC of NTS2 KO mice significantly reduced the escape latency (F (1,15) ϭ 6.32, p ϭ 0.02; Fig. 7C 1 ) and the distance traveled (F (1,15) ϭ 21.27, p Ͻ 0.001; Fig. 7C 2 ) compared with those of the NTS2 KO mice injected with saline. Similarly, NT also significantly increased the percentage of time spent in the target quadrant in the probe trial for NTS2 KO mice (Fig. 7C 3 ) indicating that NTS2 is not required in NT-induced facilitation of spatial learning and memory. However, microinjection of the same dose of NT into the EC of NTS1 KO mice failed to change significantly the escape latency (F (1,16) ϭ 0.004, p ϭ 0.95; Fig. 7C 1 ) and the distance traveled (F (1,16) ϭ 0.38, p ϭ 0.55; Fig. 7C 2 ) compared with those of the NTS1 KO mice injected with saline. NT failed to significantly alter the percentage of time spent in the target quadrant in the probe trial in NTS1 KO mice (Fig. 7C 3 ) demonstrating that NT facilitates spatial memory via activation of NTS1. Furthermore, compared with the NTS2 KO mice injected with saline, NTS1 KO mice injected with saline showed significantly increased latency (F (1,15) ϭ 13.33, p ϭ 0.0024; Fig. 7C 1 ) and lengthened distance (F (1,15) ϭ 9.31, p ϭ 0.008; Fig. 7C 2 ) . However, there was a statistically insignificant difference for the time spent in the target quadrant measured at day 12 between the NTS1 KO mice injected with saline and the NTS2 KO mice injected with saline ( p ϭ 0.24; Fig. 7C 3 ) . These results suggest that endogenously released NT also facilitates spatial learning and memory, although it may exert less effect on memory retention (see Discussion).
PKC-induced depression of TREK-2 channels is required for NT-mediated facilitation of spatial learning
Because our cellular physiology data demonstrate that PKC-induced depression of TREK-2 channels is responsible for NTinduced enhancement of neuronal excitability, we next tested whether the functions of PKC and TREK-2 channels are required for NT-induced facilitation of spatial learning. Microinjection of NT after the injection of the selective PKC inhibitor, GF109203X (50 pmol), into the EC of the mice significantly lengthened the escape latency (F (1,16) ϭ 5.97, p ϭ 0.027; Fig. 8A 1 ) and travel distance (F (1,16) ϭ 19.37, p Ͻ 0.0001; Fig. 8A 2 ) , compared with those of the mice microinjected with vehicle (DMSO) and NT. The percentage of time spent in the target quadrant in mice injected with GF109203X and NT was also significantly attenuated compared with that of the mice injected with vehicle and NT (Fig. 8A 3 ) . These data together demonstrate that PKC is required for NT-induced increases in spatial learning. Moreover, neither the escape latency (F (1,14) ϭ 0.22, p ϭ 0.65; Fig. 8B 1 ) nor the travel distance (F (1,14) ϭ 0.11, p ϭ 0.75; Fig. 8B 2 ) in TREK-2 KO mice injected with NT was significantly different from those of the TREK-2 KO mice injected with saline, whereas these parameters were still significantly reduced in WT mice injected with NT compared with those of the WT mice injected with saline (latency: F (1,13) ϭ 9.92, p ϭ 0.008; Fig. 8B 1 ; distance: F (1,13) ϭ 14.63, p ϭ 0.002; Figure 8B 2 ). Likewise, the percentage of time spent in the target quadrant in TREK-2 KO mice injected with NT was not significantly different from that of TREK-2 KO mice injected with saline, whereas the WT mice injected with NT spent more time in the target quadrant than those injected with saline (Fig. 8B 3 ) . These data together indicate that TREK-2 channels are required for NT-mediated enhancement of spatial learning. Furthermore, compared with WT mice injected with saline, TREK-2 KO mice injected with saline failed to show significant differences in latency (F (1,13) ϭ 0.0003, p ϭ 0.98; Fig. 8B 1 ) , distance traveled (F (1,13) ϭ 2.6, p ϭ 0.131; Fig. 8B 2 ), and time spent in the target quadrant measured at day 12 ( p ϭ 0.4; Fig. 8B 3 ) .
Activation of NTS1 increases neuronal excitability and facilitates spatial memory in a mouse model of AD
We then performed experiments by using APP/PS1 mice, a mouse model of AD (Garcia-Alloza et al., 2006) . We have shown Figure 6 . Microinjection of NT into the EC of rats dose-dependently increases spatial learning in the Barnes Maze Test. A, Experimental protocol used to measure spatial learning and memory of rats in the Barnes Maze Test. The protocol consisted of 5 day training (3 min per trial, 3 trials per day at an interval of 1 min) and a probe trial on day 12. B, Representative traces from the last trial of day 1 and day 5 and probe trials on day 12 in rats microinjected with saline (0.9% NaCl) and NT (0.3 nmol) . Arrow indicates the target hole. C, Mean latencies to the target hole were presented by groups. Rats were microinjected with saline and NT at doses of 0.01, 0.1, and 0.3 nmol. D, Mean distances traveled were presented in groups. E, Probe trial performance of the groups of rats injected with saline and NT (0.3 nmol) as presented by the proportion of total time spent in each quadrant.
previously that these mice exhibited plaques when they were older than 6 months (Dhawan and Combs, 2012) . We therefore used the APP/PS1 mice at the age of 8 -10 months. We first tested the effects of NT on AP firing recorded from layer II stellate neurons in the EC. The RMPs recorded from layer II stellate neurons in slices cut from APP/PS1 mice (Ϫ59.7 Ϯ 0.7 mV, n ϭ 11 cells from 4 mice) were not significantly different from those of WT mice (Ϫ60.2 Ϯ 0.5 mV, n ϭ 12 cells from 4 mice; data not shown). Bath application of NT (0.25 M) robustly increased the firing frequency of APs recorded from stellate neurons in slices cut from APP/PS1 mice (4.7 Ϯ 0.8-fold increase, n ϭ 11 cells from 4 mice, p Ͻ 0.001; Fig. 9A ). NT-induced facilitation of AP firing frequency recorded from APP/PS1 mice was not significantly different from that recorded from the age-matched WT mice (5.3 Ϯ 1.2-fold increase, n ϭ 12 cells from 4 mice, p ϭ 0.55; Fig. 9A ). Furthermore, bath application of NTS1 agonist PD149163 (0.25 M) also vigorously facilitated AP firing frequency in APP/PS1 mice (5.6 Ϯ 1.2-fold increase, n ϭ 14 cells from 4 mice, p Ͻ 0.001; Fig. 9A ). These data together demonstrate that activation of NTS1 also increases neuronal excitability in APP/PS1 mice. We then compared the spatial learning and memory ability of APP/PS1 mice with the WT mice using the Barnes Maze Test. Compared with the age-matched WT mice, APP/PS1 mice exhibited significantly enhanced latency (F (1,15) ϭ 15.39, p ϭ 0.001; Fig. 9B 1 ) , lengthened travel distance (F (1,15) ϭ 6.42, p ϭ 0.023; Fig. 9B 2 ), and decreased percentage of the time spent in the target quadrant ( p ϭ 0.02; Fig. 9B 3 ) . These results indicate that APP/PS1 mice showed impaired cognitive functions. We further tested the effects of PD149163 on spatial learning and memory in APP/PS1 mice. Bilateral microinjection of PD149163 (0.3 nmol) significantly reduced the escape latency (F (1,14) ϭ 28.89, p Ͻ 0.0001; Fig. 9B 1 ) and the distance traveled (F (1,14) ϭ 23.47, p Ͻ 0.001; Fig. 9B 2 ) but significantly increased the percentage of time spent in the target quadrant (Fig. 9B 3 ) demonstrating that PD149163 improves spatial learning and memory in APP/PS1 mice.
Discussion
Our results demonstrate that activation of NTS1 receptors in the EC generates persistent increases in neuronal excitability. NTinduced increases in neuronal excitability are mediated by phosphorylation and inhibition of TREK-2 channels and require the functions of G-proteins, PLC and PKC. Activation of NTS1 facilitates spatial learning and memory via PKC-dependent downregulation of TREK-2 channels, suggesting that NT-induced facilitation of neuronal excitability is a novel cellular and molecular substrate for learning and memory. Furthermore, applications of NT and NTS1 agonist, PD149163, also increase AP firing in slices cut from APP/PS1 mice and microinjection of PD149163 into the EC of APP/PS1 mice significantly increased the spatial learning and memory of these mice, suggesting that NTS1 agonists exert beneficial effects at least on AD animal models.
Ionic mechanisms underlying NTS1-mediated increase in neuronal excitability and facilitation of spatial learning Application of NT increases neuronal excitability by depolarizing entorhinal neurons suggesting that activation of NTS1 receptors modifies the movement of ions across the membrane, which is usually conducted by ion channels or transporters. NT has been shown to inhibit Na ϩ /K ϩ pump (Ló pez Ordieres and Rodríguez de Lores Arnaiz, 2000). The Na ϩ /K ϩ pump creates a concentration gradient by moving 3 Na ϩ out and 2 K ϩ into cells and inhibition of this pump, thereby, should create a net accumulation of positive ions inside cells leading to depolarization. Extracellular K ϩ is a requisite for the function of the Na ϩ /K ϩ pump. Our result that removal of extracellular K ϩ did not block but significantly increased NT-induced inward HCs demonstrates that NT increases neuronal excitability unlikely by inhibition of Na ϩ /K ϩ pump. One explanation for NTinduced higher level of inward HCs in the absence of extracellular K ϩ is that depletion of extracellular K ϩ increases the driving force for K ϩ efflux via K ϩ channels leading to stronger inhibition of K ϩ channels by NT.
Our results demonstrate that NT facilitates neuronal excitability by inhibition of background K ϩ channels based on the following lines of evidence. First, NT significantly increased the input resistance, suggesting that NT inhibits a membrane conductance. Second, replacing intracellular K ϩ with Cs ϩ blocked NT-induced inward HCs. Third, the reversal potential of NT-induced currents had a reversal potential close to the K ϩ reversal potential. Nonetheless, the involved K ϩ channels are unlikely to be the inwardly rectifier K ϩ channels because the I-V curve of NT-sensitive currents did not show inward rectification, but a little outward rectification and application of the inward rectifier K ϩ channel blocker tertiapin-Q failed to significantly alter NT-induced inward HCs. Moreover, SCH23390 is an antagonist of D 1 -like receptors as well as a blocker for inward rectifier K ϩ channels (Kuzhikandathil and Oxford, 2002) . Our result that application of SCH23390 failed to alter NT-induced facilitation of AP firing frequency (Fig. 1F ) further excludes the participation of inward rectifier K ϩ channels. The results that NT-induced inward HCs were insensitive to the classical K ϩ channel blockers, such as TEA, 4-AP, and extracellular Cs ϩ , suggest that NT inhibits K 2P channels. NT has been reported to inhibit a type of K 2P channels (possibly TRESK and/or TASK-3) in spinal cord neurons (Kadiri et al., 2011) . However, the channels inhibited by NT in the spinal cord neurons are sensitive to both Ba 2ϩ and Zn 2ϩ (Kadiri et al., 2011) , which is in contrast to our results that NTinduced inward HCs in the EC were sensitive to Ba 2ϩ but insensitive to Zn 2ϩ . These results suggest that NT inhibits a different type of K 2P channels in the EC. We provide further evidence demonstrating that NT increases neuronal excitability by inhibition of TREK-2 channels. Application of NT failed to increase the AP firing frequency in slices cut from TREK-2 KO mice, whereas application of NT still robustly increased AP firing frequency in slices cut from WT mice. Bath application of NT to HEK293 cells coexpressing NTS1 and TREK-2 channels induced an inward HC, whereas NT failed to modify the HCs in HEK293 cells transfected with either NTS1 receptors or TREK-2 channels alone. These results together indicate that NT inhibits TREK-2 channels to increase the excitability of entorhinal neurons.
Although we have demonstrated that NT-induced facilitation of neuronal excitability is unlikely because of its indirect effects on the releases of glutamate, GABA, DA, and Ach, the potential indirect contributions of other factors, such as the serotoninergic, purinergic, glycinergic, and other peptidergic systems, have not been examined. However, it seems less likely that the effects of NT would be related to serotonin or glycine because both serotonin (Lei, 2012) and glycine (Breustedt et al., 2004) inhibit neuronal excitability in the EC. The potential interaction between NT and other neurotransmitters still needs further investigation.
Signaling mechanisms underlying NTS1-induced facilitation of neuronal excitability and augmentation of spatial learning in the EC Whereas NT interacts with NTS1, NTS2, and NTS3 receptors, our results demonstrate that NT increases neuronal excitability and facilitates spatial learning via activation of NTS1 receptors based on the results from both pharmacological experiments and KO mice. Activation of NTS1 increases the activity of PLC leading to elevation of intracellular Ca 2ϩ release and activation of PKC. Our results demonstrate that NT-induced facilitation of neuronal excitability is related to intracellular Ca 2ϩ level because intra- 2ϩ -dependent PKC, is necessary for NT-induced facilitation of neuronal excitability. We further demonstrate that NT induces persistent phosphorylation of TREK-2 channels. In HEK293 cells coexpressing NTS1 and the TREK-2 mutant in which serine 326 and serine 359 were mutated to alanine, NT failed to induce an inward HC, suggesting that PKC phosphorylates TREK-2 channels on these two sites. Consistent with our results, PKC-dependent phosphorylation of TREK-2 channels on these two amino acids by activation of muscarinic receptors (Kang et al., 2006) and AMPactivated protein kinase (Kréneisz et al., 2009 ) also results in inhibition of TREK-2 channels. PKC-dependent phosphorylation and inhibition of TREK-2 channels likely contribute to NT-mediated facilitation of spatial learning because inhibition of PKC or deletion of TREK-2 gene nullified the facilitatory effects of NT on spatial learning. However, the specific PKC isoforms involved in NTmediated facilitation of neuronal excitability and spatial learning still await further investigation. In line with our results, it is well established that both PKC (Bonini et al., 2007; Dash et al., 2007; Sun and Alkon, 2010) and TREK-2 channels (Pan et al., 2003; Huang and Yu, 2008; Deng et al., 2009 ) are substrates of learning and memory.
Whereas our results demonstrate that both NTS1 and TREK-2 channels are required for NT-induced facilitation of spatial learning, the roles of NTS1 and TREK-2 channels in the modulation of spatial learning by endogenously released NT are still elusive. NTS1 KO mice showed increased escape latency and travel distance, suggesting that NTS1 activated by endogenously released NT is involved in the processes of spatial learning. However, the percentage of time spent in the target quadrant in the probe test measured on day 12 was not altered in NTS1 KO mice, suggesting that NTS1 may play a less important role in memory retention. Moreover, TREK-2 KO mice showed no differences in spatial learning and memory, although acute microinjection of NT into the EC of TREK-2 KO mice failed to facilitate spatial learning and memory, demonstrating a role of TREK-2 channels in exogenously applied NT. One explanation for the discrepancy of these results is that the roles of TREK-2 channels may be replaced by other K 2P channels in TREK-2 KO mice because the electrophysiological properties, such as the RMPs, were not changed in these mice. Evidence supporting this possibility comes from the observations that the RMPs of neurons in TREK-1 (Heurteaux et al., 2004) or TASK-1 (Aller et al., 2005 ) KO mice were not changed either. Moreover, although our results demonstrate that TREK-2 channel is the major target of NTS1 receptors, the possibility that an alternative target for endogenously released NT has been developed in TREK-2 KO mice cannot be excluded.
Significance of NTS1-induced enhancement of neuronal excitability and spatial learning in AD There is increasing evidence demonstrating that the functions of NT are closely associated with the memory status of both animals and humans. For example, in healthy adult humans, NTS1 polymorphisms are closely associated with variance in the performance of working memory (Li et al., 2011) . NT binding sites are varied as a function of age and cognitive status with decreased NT binding sites in the brains of aged and cognitively impaired rats (Rowe et al., 2006) . Application of NT or NT receptor agonists improves memory (Azmi et al., 2006; Ohinata et al., 2007; László et al., 2010) , whereas administration of NT receptor antagonists impairs cognitive processes (Tirado-Santiago et al., 2006) . Whereas the effects of NT on memory are usually considered to be mediated by NTS1 (Azmi et al., 2006; Tirado-Santiago et al., 2006; Ohinata et al., 2007; László et al., 2010) , reduced fear memory has also been observed in NTS2 KO mice (Yamauchi et al., 2007) . Although these data generally support a role for NT in learning and memory, the cellular and molecular mechanisms whereby NT facilitates memory have not been determined. In the present study, we took the advantage that high density of NT receptors is expressed in the superficial layers of the EC, an indispensable structure involved in learning and memory. We first examined the effects of NT on neuronal excitability, and our results demonstrated that brief (5 min) application of NT persistently increased the AP firing frequency. This phenomenon resembles the long-term potentiation. Whereas long-term potentiation is generally considered as a cellular and molecular substrate for learning and memory, the eventual outcome of long-term potentiation is to increase the excitability of the postsynaptic neurons. NT-induced persistent increase in neuronal excitability bypasses the processes of synaptic transmission and directly leads to increases in neuronal excitability. Thus, it is reasonable to speculate that NT-induced persistent increase in neuronal excitability may represent a novel cellular mechanism involved in learning and memory.
Memory impairment is a characteristic symptom observed in many diseases, such as AD. Up to date, there have been few effective drugs that can relieve the memory loss of these diseases. Grid cell firing correlates to forming an internal spatial map and is driven by the polymodal input to the EC that occurs as an animal explores its environment (Sargolini et al., 2006; Hafting et al., 2008; Brandon et al., 2011; Burgalossi et al., 2011) . We propose that NT may increase the probability of grid cell firing in response to that input, which promotes a more active circuit in the encoding of information about one's environment. Our data clearly show that application of NT or NTS1 agonist PD149163 facilitates spatial learning. We further showed that microinjection of PD149163 into the EC of APP/PS1 mice also significantly improved the memory status of these mice, highlighting a therapeutic value of this type of drugs in AD. Therefore, one immediate implication of our results is that NTS1 agonists may have the potential to be developed as cognition-enhancing drugs to relieve the symptoms of AD.
In conclusion, we found that activation of NTS1 receptors in the EC induces a persistent increase in AP firing and facilitates spatial learning. NT-induced facilitation of neuronal excitability and spatial learning require the functions of PLC and PKC and are mediated by phosphorylation and inhibition of TREK-2 channels. NT and NTS1 agonist PD149163 also induced persistent AP firing and facilitated spatial memory in APP/PS1 mice, suggesting that NT-mediated augmentation of learning and memory may have therapeutic potentials to relieve memory loss exhibited in AD.
